Vasculogenic mimicry in non-small cell lung cancer: a systematic review
Vasculogenic mimicry (VM), a non-endothelial tumor blood supply mechanism linked to poor prognosis in various cancers, requires consolidated prognostic evaluation in non-small cell lung cancer (NSCLC). This systematic review synthesized evidence on VM’s association with survival outcomes (OS, DFS, P...
Saved in:
Main Authors: | Valeriia Shapkina, Vadim Shindyapin, Nikita Burlov, Elizaveta Prosekina, Anna Artemyeva |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1481726/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The balance between deception and adaptation: vasculogenic mimicry as a tumor survival strategy
by: E. A. Prosekina, et al.
Published: (2025-04-01) -
A novel vasculogenic mimicry-related nomogram predicts prognosis in hepatocellular carcinoma
by: Yun Zhong, et al.
Published: (2025-07-01) -
Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery
by: Siqi Wu, et al.
Published: (2025-06-01) -
Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
by: Jing-Jing Liu, et al.
Published: (2019-12-01) -
Immunohistochemistry for Assessing Toxicity and Mechanism of Action of Anticancer Drugs During Preclinical Trials. Part II. Cell Death, Vasculogenesis and Angiogenesis
by: M. A. Akimenko, et al.
Published: (2024-06-01)